Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens

No abstract is available for this paper.

• Publication year

  2002

• Venue

  European Journal of Immunology

• Publication date

  2002-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/1521-4141(200211)32:11<3267::AID-IMMU3267>3.0.CO;2-1PMID 12555672
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice.

  2002cited by this paper
• Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human Blood

  2001cited by this paper
• Topoisomerase I Inhibitors with an Indolocarbazole Structure Transporter as a Transporter of NB-506 and J-107088 , Resistance / Placenta-Specific , ATP-binding Cassette Identification of Breast Cancer Resistant Protein / Mitoxantrone Updated

  2001cited by this paper
• Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

  2001cited by this paper
• Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses

  2001cited by this paper
• Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

  2001cited by this paper
• Identification and Functional Characterization of Human Cd4+Cd25+ T Cells with Regulatory Properties Isolated from Peripheral Blood

  2001cited by this paper
• Cutting Edge: Control of CD8+ T Cell Activation by CD4+CD25+ Immunoregulatory Cells

  2001cited by this paper
• Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor β

  2001cited by this paper
• Human Cd25+Cd4+ T Regulatory Cells Suppress Naive and Memory T Cell Proliferation and Can Be Expanded in Vitro without Loss of Function

  2001cited by this paper
• Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activity in vitro

  2001cited by this paper
• An Immunodominant MHC Class II-Restricted Tumor Antigen Is Conformation Dependent and Binds to the Endoplasmic Reticulum Chaperone, Calreticulin1

  2001cited by this paper
• Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

  2001cited by this paper
• Regulatory T cells in the control of immune pathology

  2001cited by this paper
• Immunization with a tumor‐associated CTL epitope plus a tumor‐related or unrelated Th1 helper peptide elicits protective CTL immunity

  2001cited by this paper
• IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo1

  2001cited by this paper
• Characterization of Peripheral Regulatory CD4+ T Cells That Prevent Diabetes Onset in Nonobese Diabetic Mice1

  2000cited by this paper
• Eradication of established tumors by CD8+ T cell adoptive immunotherapy.

  2000cited by this paper
• Dendritic cell maturation is induced by mycoplasma infection but not by necrotic cells

  2000cited by this paper
• Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation

  2000cited by this paper
• B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.

  2000cited by this paper
• Regulatory T cells in autoimmmunity*.

  2000cited by this paper
• Mice vaccination with interleukin 12-transduced colon cancer cells potentiates rejection of syngeneic non-organ-related tumor cells.

  2000cited by this paper
• The makings of a tumor rejection antigen.

  1999cited by this paper
• Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.

  1999cited by this paper
• Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.

  1999cited by this paper
• Monoclonal antibody therapy of B cell lymphoma: signaling activity on tumor cells appears more important than recruitment of effectors.

  1998cited by this paper
• Induction of antigen-specific T cell anergy: An early event in the course of tumor progression.

  1998cited by this paper
• The shared tumor‐specific antigen encoded by mouse gene P1A is a target not only for cytolytic T lymphocytes but also for tumor rejection

  1998cited by this paper
• Cancer Tumor antigens.

  1997cited by this paper
• CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma

  1997cited by this paper
• The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product.

  1996cited by this paper
• A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

  1996cited by this paper
• A unique tumor antigen produced by a single amino acid substitution.

  1995cited by this paper
• CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma

  1994cited by this paper
• Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

  1993cited by this paper
• Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells

  1992cited by this paper
• Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen

  1988cited by this paper
• CD4 monoclonal antibody pairs for immunosuppression and tolerance induction

  1987cited by this paper
• Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells

  1985cited by this paper
• Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle.

  1985cited by this paper
• High and low affinity IL 2 receptors: analysis by IL 2 dissociation rate and reactivity with monoclonal anti-receptor antibody PC61.

  1985cited by this paper
• Mechanism of recovery from acute virus infection. I. Role of T lymphocytes in the clearance of lymphocytic choriomeningitis virus from spleens of mice.

  1985cited by this paper
• Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo

  1984cited by this paper
• Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure.

  1975cited by this paper
• A murine renal cell carcinoma.

  1973cited by this paper
• Immunity to methylcholanthrene-induced sarcomas.

  1957cited by this paper

• Temporal and Context-Dependent Requirements for the Transcription Factor Foxp3 Expression in Regulatory T Cells

  2025cites this paper
• Temporal and context-dependent requirements for the transcription factor Foxp3 expression in regulatory T cells

  2025cites this paper
• Towards effective CAIX-targeted radionuclide and checkpoint inhibition combination therapy for advanced clear cell renal cell carcinoma

  2024cites this paper
• Antisense targeting of FOXP3+ Tregs to boost anti-tumor immunity

  2024cites this paper
• Regulatory T Cell Inhibition by P60 Combined with Adenoviral AFP Transduced Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma

  2023cites this paper
• CD8+ T Cell-Mediated Therapeutic Antitumor Effect of an Herbal Mixture Containing Ganoderma lucidum

  2023cites this paper
• Toxoplasma gondii gra5 deletion mutant protects hosts against Toxoplasma gondii infection and breast tumors

  2023cites this paper
• Isolation and Analysis of Tumor-Infiltrating Treg.

  2023cites this paper
• FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms

  2022cites this paper
• Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 Antibody

  2022cites this paper
• Japanese Kampo Medicine Juzentaihoto Improves Antiviral Cellular Immunity in Tumour-Bearing Hosts

  2022cites this paper
• Regulatory T-Cells as an Emerging Barrier to Immune Checkpoint Inhibition in Lung Cancer

  2021cites this paper
• Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop.

  2021cites this paper
• Involvement of Cellular Prion Protein in Invasion and Metastasis of Lung Cancer by Inducing Treg Cell Development

  2021cites this paper
• Tumor-Derived Exosomes Enriched by miRNA-124 Promote Anti-tumor Immune Response in CT-26 Tumor-Bearing Mice

  2021cites this paper
• A Cross-Species Reactive TIGIT-Blocking Antibody Fc Dependently Confers Potent Antitumor Effects

  2020cites this paper
• Regulatory T Cells in Cancer Immunotherapy: Basic Research Outcomes and Clinical Directions

  2020cites this paper
• Japanese Kampo Medicine Juzentaihoto Enhances Antitumor Immunity in CD1d−/− Mice Lacking NKT Cells

  2020cites this paper
• CMAR_A_265828 10411..10421

  2020cites this paper
• CD25-Treg-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity

  2020cites this paper
• NKG2D-Fc fusion protein promotes antitumor immunity through the depletion of immunosuppressive cells

  2020cites this paper
• Primary breast tumours but not lung metastases induce protective anti-tumour immune responses after Treg-depletion

  2020cites this paper
• Immunopathology as a Basis for Immunotherapy of Head and Neck Squamous Cell Carcinoma

  2020cites this paper
• Regulatory T Cells in Cancer Immunotherapy: Basic Research Outcomes and Clinical Directions

  2020cites this paper
• CCL22 Signaling in the Tumor Environment.

  2020cites this paper
• Depletion of regulatory T cells in tumors with an anti-CD25 immunotoxin induces CD8 T cell-mediated systemic antitumor immunity

  2019cites this paper
• The Effect of Antibody Fragments on CD25 Targeted Regulatory T Cell Near Infrared Photoimmunotherapy (NIR-PIT).

  2019cites this paper
• Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4+CD25+Foxp3+ and CD4+CD25−Foxp3+ T cells

  2019cites this paper
• A functional interaction between the CCR5 and CD34 molecules expressed in hematopoietic cells can support (or even promote) the development of cancer

  2019cites this paper
• CCL3 augments tumor rejection and enhances CD8+ T cell infiltration through NK and CD103+ dendritic cell recruitment via IFNγ

  2018cites this paper
• Regulatory T cells

  2018cites this paper
• T Cell Responses

  2018cites this paper
• Protective low-avidity anti-tumour CD8+ T cells are selectively attenuated by regulatory T cells

  2018influential citation
• Targeting regulatory T cells for improving cancer therapy: Challenges and prospects

  2018cites this paper
• Attenuated in vitro effects of IFN‐&agr;, IL‐2 and IL‐12 on functional and receptor characteristics of peripheral blood lymphocytes in metastatic melanoma patients

  2017cites this paper
• Association of Marek’s Disease induced immunosuppression with activation of a novel regulatory T cells in chickens

  2017cites this paper
• Japanese Kampo medicine ninjin'yoeito synergistically enhances tumor vaccine effects mediated by CD8+ T cells

  2017cites this paper
• The γ c family of cytokines: fine-tuning signals from IL-2 and IL-21 in the regulation of the immune response

  2017cites this paper
• Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors

  2017influential citation
• Immunity Report Fc-Optimized Anti-CD 25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors

  2017influential citation
• Tumor-associated Glycans and Tregs in Immunogenicity of an Autologous Cell-based Vaccine

  2016cites this paper
• Understanding Tumor-Antigen Presentation in the New Era of Cancer Immunotherapy.

  2016cites this paper
• Rationale of hyperthermia for radio(chemo)therapy and immune responses in patients with bladder cancer: Biological concepts, clinical data, interdisciplinary treatment decisions and biological tumour imaging

  2016cites this paper
• Cellular and molecular events controlling acquisition of cytotoxic activity by melanoma-reactive CD4⁺ T cells in vivo

  2016cites this paper
• The role of glycosylation in regulatory T-cell biology

  2016cites this paper
• T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?

  2015cites this paper
• Immunotherapy of Metastatic Colorectal Cancer: Prevailing Challenges and New Perspectives

  2015cites this paper
• Immunopathology of Head and Neck Tumors and Immunotherapy of Squamous Cell Carcinoma

  2015cites this paper
• Manipulation of regulatory T cells and antigen‐specific cytotoxic T lymphocyte‐based tumour immunotherapy

  2015cites this paper
• Glioma

  2015cites this paper
• Generation of mycophenolate mofetil resistant lymphocytes for adoptive immunotherapy

  2015cites this paper
• Differential potency of regulatory T cell-mediated immunosuppression in kidney tumors compared to subcutaneous tumors

  2014cites this paper
• Photodynamic therapy downregulates the function of regulatory T cells in patients with esophageal squamous cell carcinoma

  2014cites this paper
• Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines

  2014cites this paper
• Low pathogenic human enteroviruses as novel anti-cancer agents against malignant glioma

  2014cites this paper
• The immunoregulatory role of type I and type II NKT cells in cancer and other diseases

  2014cites this paper
• Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects.

  2014cites this paper
• Cancer immunotherapy using tumor cryoablation.

  2014cites this paper
• Regulatory T Cells in Cancer Patients and Their Roles in Cancer Development/Progression

  2014cites this paper
• Inflammatory and immune reactions in response to chemotherapy-induced cell death

  2013cites this paper
• Suppression, subversion and escape: the role of regulatory T cells in cancer progression

  2013cites this paper
• Tumor-stromal interactions in pancreatic cancer.

  2013cites this paper
• Tumor-Infiltrating Regulatory T Cells Inhibit Endogenous Cytotoxic T Cell Responses to Lung Adenocarcinoma

  2013cites this paper
• Intrinsic immune alterations in renal cell carcinoma and emerging immunotherapeutic approaches

  2013cites this paper
• Advances in Biology and Therapy of Multiple Myeloma

  2013cites this paper
• Liver immunology.

  2013cites this paper
• Photodynamic therapy plus regulatory T-cell depletion produces immunity against a mouse tumour that expresses a self-antigen

  2013cites this paper
• Regulatory T-cells in chronic lymphocytic leukemia: actor or innocent bystander?

  2013cites this paper
• Schedule-dependent therapeutic efficacy of L19mTNF-α and melphalan combined with gemcitabine

  2013cites this paper
• Cytokines in the Treatment of Cancer

  2013cites this paper
• Induction of Protective Antitumor Immunity through Attenuation of ERAAP Function

  2013cites this paper
• DelicateBalanceamongThreeTypesofTCellsinConcurrent Regulation of Tumor Immunity

  2013cites this paper
• with GITR inhibitory activity: a novel regulatory role for OX40 and its comparison Triggering of OX40 (CD134) on CD4+CD25+ T cells blocks their

  2013cites this paper
• Rekombinantní vakcíny proti solidním a hematologickým nádorům: vývoj a stanovení jejich účinnosti

  2013cites this paper
• Pathogenesis of Endemic Burkitt's Lymphoma: The Role of T-Cell Responses

  2013cites this paper
• Defining Multiple Myeloma as a Target for DNA Vaccines

  2013cites this paper
• Tumor-Derived TGF- CD4+CD25+ T Regulatory Cells: Role of T Cells into - Converting CD4+CD25 Tumor Evasion of the Immune System by

  2013cites this paper
• Sclareol reduces CD4+ CD25+ FoxP3+ Treg cells in a breast cancer model in vivo.

  2013cites this paper
• through Attenuation of ERAAP Function Induction of Protective Antitumor Immunity

  2013cites this paper
• Managing Regulatory T Cells to Improve Cancer Immunotherapy

  2013cites this paper
• [The role of regulatory T cells in the modulation of anti-tumor immune response].

  2013cites this paper
• This information is current as Responses to Lung Adenocarcinoma Inhibit Endogenous Cytotoxic T Cell Tumor-Infiltrating Regulatory T Cells

  2013cites this paper
• CCL22, CD8 und FoxP3 als prognostische Marker beim fortgeschrittenen Ovarialkarzinom-

  2013cites this paper
• This information is current as Occurring T Regulatory Cells T Helper Cells and Hindered by Naturally + Tumor/Self-Antigen Is Augmented by CD4 T Cell Immunity Against a + CD8

  2013cites this paper
• Dual role of heat shock proteins (HSPs) in anti-tumor immunity.

  2012cites this paper
• Examining autoimmune sequelae during cancer immunotherapy in a combined autoimmune thyroiditis and tumor mouse model

  2012cites this paper
• Modulation Of Anti-Tumor Immune Response By Tgf-Β-Inducible Early Gene 1 (tieg1)

  2012cites this paper
• The Indispensable Role of CCR5 for In Vivo Suppressor Function of Tumor-Derived CD103+ Effector/Memory Regulatory T Cells

  2012cites this paper
• tolerance after stem cell transplantation Induction of type I IFN is required for overcoming tumor-specific T-cell

  2012cites this paper
• Immunotherapeutic approach with oligodeoxynucleotides containing CpG motifs (CpG-ODN) in malignant glioma.

  2012cites this paper
• Using Natural Adjuvants to Stimulate Anti-Tumour Immune Responses

  2012cites this paper
• Absence of CD4 T-cell help provides a robust CD8 T-cell response while inducing effective memory in a preclinical model of melanoma.

  2012cites this paper
• Effector/Memory Regulatory T Cells + CD103Suppressor Function of Tumor-Derived The Indispensable Role of CCR5 for In Vivo

  2012cites this paper
• Creating and Use of an New Experimental Preclinical HLA Transgenic Mice Model to Mapping HLA-restricted T Cells Epitopes for Polyepitopes Vaccine Design

  2012cites this paper
• Can breast cancer stem cells evade the immune system?

  2012cites this paper
• Regulatory T cells in cancer

  2012cites this paper
• Alpha-fetoprotein and immunotherapy for hepatocellular carcinoma

  2012cites this paper
• Influence of tumors on protective anti-tumor immunity and the effects of irradiation

  2012cites this paper
• Regulatory T Cells in Human Ovarian Cancer

  2012cites this paper
• Induction of apoptosis-resistant and TGF-β-insensitive murine CD8(+) cytotoxic T lymphocytes specific for HIV-1 gp160.

  2012cites this paper